Spinal Muscular Atrophy (SMA) Biomarker Study (U01)
Funding Contact(s): Elizabeth McNeil, M.D., M.Sc.
Funding Categories: Clinical Research
Brief Description:
The purpose of this funding opportunity announcement (FOA), issued by NINDS, is to invite applications for a study of candidate
biomarkers in Spinal Muscular Atrophy (SMA). The study will be done using the NeuroNEXT infrastructure (as established in
response to RFA-NS-11-009, RFA-NS-11-010, RFA-NS-11-008) along with ad hoc clinical sites as appropriate. This is a milestone-driven
cooperative agreement program involving participation of NIH staff in the development of the project plan and monitoring of
research progress.